Asia Deal Watch: Nxera Out-Licenses CPCR-Targeted Asset To Unnamed Start-Up

 
• By Joseph Haas, Lisa Takagi, Xu Hu, and Dexter Jie Yan
  
Asia Deal Watch
• Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deal Watch

More from Deals